NO994330D0 - Metode for behandling av en tumor - Google Patents

Metode for behandling av en tumor

Info

Publication number
NO994330D0
NO994330D0 NO994330A NO994330A NO994330D0 NO 994330 D0 NO994330 D0 NO 994330D0 NO 994330 A NO994330 A NO 994330A NO 994330 A NO994330 A NO 994330A NO 994330 D0 NO994330 D0 NO 994330D0
Authority
NO
Norway
Prior art keywords
mammal
administering
effective amount
tumor
treating
Prior art date
Application number
NO994330A
Other languages
English (en)
Other versions
NO994330L (no
NO324974B1 (no
Inventor
Daniel L Dexter
Paul E Juniewicz
James B Rake
Daniel D Von Hoff
Original Assignee
Sanofi Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Winthrop Inc filed Critical Sanofi Winthrop Inc
Publication of NO994330D0 publication Critical patent/NO994330D0/no
Publication of NO994330L publication Critical patent/NO994330L/no
Publication of NO324974B1 publication Critical patent/NO324974B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO19994330A 1997-03-07 1999-09-06 Anvendelse av 3-amino-1,2,4-benzotriazin-1,4-dioksyd/paclitaxel/platina for fremstilling av et preparat for behandling av et pattedyr som har en fast tumor samt kit inneholdende nevnte preparat. NO324974B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81476997A 1997-03-07 1997-03-07
PCT/US1998/003292 WO1998039009A1 (en) 1997-03-07 1998-02-17 Method of treating a tumor

Publications (3)

Publication Number Publication Date
NO994330D0 true NO994330D0 (no) 1999-09-06
NO994330L NO994330L (no) 1999-10-25
NO324974B1 NO324974B1 (no) 2008-01-14

Family

ID=25215967

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994330A NO324974B1 (no) 1997-03-07 1999-09-06 Anvendelse av 3-amino-1,2,4-benzotriazin-1,4-dioksyd/paclitaxel/platina for fremstilling av et preparat for behandling av et pattedyr som har en fast tumor samt kit inneholdende nevnte preparat.

Country Status (15)

Country Link
US (2) US6063780A (no)
EP (1) EP1014990B1 (no)
JP (1) JP2001513110A (no)
AT (1) ATE338553T1 (no)
AU (1) AU6178198A (no)
BR (1) BR9808221A (no)
CA (1) CA2281807C (no)
DE (1) DE69835824T2 (no)
DK (1) DK1014990T3 (no)
ES (1) ES2268764T3 (no)
HR (1) HRP980095A2 (no)
NO (1) NO324974B1 (no)
PT (1) PT1014990E (no)
WO (1) WO1998039009A1 (no)
ZA (1) ZA981609B (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1014990B1 (en) * 1997-03-07 2006-09-06 Sanofi-Aventis U.S. LLC Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum
BRPI9914508B8 (pt) 1998-10-14 2021-05-25 Debiopharm Sa bolsa flexível impermeável para uso médico contendo uma preparação farmacêutica de oxaliplatina sob a forma líquida
DE19925211B4 (de) * 1999-06-01 2006-01-12 PBS Pharmaceutical Bulk Substances SA Kit zur Herstellung einer Formulierung von Paclitaxel
ES2206288T3 (es) * 1999-08-30 2004-05-16 Debiopharm S.A. Preparacion farmaceutica estable de oxiliplatino para su administracion por via parenteral.
US7070796B1 (en) 1999-08-30 2006-07-04 Debiopharm S.A. Pharmaceutically stable oxaliplatinum preparation for parenteral administration
EP1341555A2 (fr) 2000-12-12 2003-09-10 Debiopharm S.A. Preparation pharmaceutique d'oxaliplatine pour administration par voie parenterale et procede d'obtention de ladite preparation
US6476068B1 (en) 2001-12-06 2002-11-05 Pharmacia Italia, S.P.A. Platinum derivative pharmaceutical formulations
AU2003261354A1 (en) * 2002-08-02 2004-02-23 The Regents Of The University Of California New uses for inhibitors of inosine monophosphate dehydrogenase
WO2004103344A1 (en) * 2003-05-20 2004-12-02 Aronex Pharmaceuticals, Inc. Combination chemotherapy comprising a liposomal platinum complex
US7989490B2 (en) * 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US20060275331A1 (en) * 2004-08-31 2006-12-07 Borek Zaludek Pharmaceutical composition, method of manufacturing and therapeutic use thereof
JP2006248978A (ja) 2005-03-10 2006-09-21 Mebiopharm Co Ltd 新規なリポソーム製剤
WO2007041546A2 (en) * 2005-10-03 2007-04-12 Genetix Pharmaceuticals, Inc. Method for selectively depleting hypoxic cells
US20070212360A1 (en) * 2006-01-17 2007-09-13 Denko Nicholas C Modulation of mitochondrial oxygen consumption for therapeutic purposes
US8026017B2 (en) 2007-03-16 2011-09-27 The United States Of America As Represented By The Secretary Of The Army High voltage methanol fuel cell assembly using proton exchange membranes and base/acid electrolytes
US8591921B2 (en) 2008-04-10 2013-11-26 Virginia Commonwealth University Induction of tumor hypoxia for cancer therapy
US9278124B2 (en) 2012-10-16 2016-03-08 Halozyme, Inc. Hypoxia and hyaluronan and markers thereof for diagnosis and monitoring of diseases and conditions and related methods
EP4201403A1 (en) * 2021-12-21 2023-06-28 Som Innovation Biotech, S.L. Compounds tirapazamine and quazinone for use in the treatment of gm2 gangliosidoses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5484612A (en) * 1993-09-22 1996-01-16 The Board Of Trustees Of The Leland Stanford Junior University Method of treating a mammal having a solid tumor susceptible to treatment with cisplatin
EP1014990B1 (en) * 1997-03-07 2006-09-06 Sanofi-Aventis U.S. LLC Antitumor combination of 3-amino-1,2,4-benzotriazine 1,4-dioxide/paclitaxel/platinum

Also Published As

Publication number Publication date
JP2001513110A (ja) 2001-08-28
EP1014990A4 (en) 2004-03-24
PT1014990E (pt) 2006-11-30
US6319923B1 (en) 2001-11-20
CA2281807A1 (en) 1998-09-11
NO994330L (no) 1999-10-25
DK1014990T3 (da) 2006-12-11
ES2268764T3 (es) 2007-03-16
DE69835824T2 (de) 2007-03-29
ZA981609B (en) 1998-12-08
DE69835824D1 (de) 2006-10-19
US6063780A (en) 2000-05-16
AU6178198A (en) 1998-09-22
WO1998039009A1 (en) 1998-09-11
EP1014990A1 (en) 2000-07-05
BR9808221A (pt) 2000-05-16
ATE338553T1 (de) 2006-09-15
CA2281807C (en) 2007-10-16
NO324974B1 (no) 2008-01-14
EP1014990B1 (en) 2006-09-06
HRP980095A2 (en) 1998-12-31

Similar Documents

Publication Publication Date Title
NO994330L (no) Metode for behandling av en tumor
DK1068870T3 (da) Antitumormidler
DE59709437D1 (de) Neue phenanthridine
ATE207355T1 (de) Behandlung von hyperproliferativen gefässerkrankungen
DE69807349T2 (de) Thyroxin-analoga ohne bedeutende hormonale wirkung zur behandlung von bösartigen tumoren
ATE258796T1 (de) Verwendung von vitamin d4-derivaten zur behandlung von hauterkrankungen
PT902789E (pt) Derivados de androsteno
PL340679A1 (en) Application of a mixture of diole and alpha-hydroxyacid in treating
DE69612056D1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
ATE317263T1 (de) Diphosphonat derivate von therapeutisch wirksamen stoffen
DE69814691D1 (de) Verwendung von fc101 als hemmstoff der angiogenese zur behandlung von krebs und anderen angiogenen krankheiten
ATE204476T1 (de) Verwendung von 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazi e zur herstrllung eines medikaments zur behandlung von bestimmten schmerzen und ödem
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
DE69426986D1 (de) Behandlung von laminitis
RU94024337A (ru) Антиметастатическое средство
ATE271867T1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
DE69635282D1 (de) Behandlung der exzessiven aggressivität mit olanzapine